KATY, Texas, June 5, 2026 /PRNewswire/ -- Academy Sports and Outdoors, Inc. (the "Company" or "Academy") (Nasdaq: ASO) announced today that on June 4, 2026,...
MONROE TOWNSHIP, N.J., June 05, 2026 (GLOBE NEWSWIRE) -- Ocean Power Technologies, Inc. (NYSE American: OPTT) (“OPT” or the “Company”), today announced that it has entered into securities purchase agreements with certain institutional investors for the purchase and sale of 25,000,000 shares of the Company’s common stock together with common warrants to purchase up to 25,000,000 shares of common stock in a registered direct offering at a combined purchase price of $0.40 per share of common stock and accompanying common warrant. The offering was priced at a premium to yesterday’s closing price. The common warrants will be exercisable on the six month anniversary of the date of issuance at an exercise price of $0.40 per share and will expire 6 years from the initial date of exercise.
Recognition follows approximately $5 million in strategic capital raises and continued execution of Turbo Energy's global AI-driven energy infrastructure growth strategy
Recognition follows approximately $5 million in strategic capital raises and continued execution of Turbo Energy's global AI-driven energy infrastructure growth strategy
ISTANBUL, June 5, 2026 /PRNewswire/ -- Beko, a leading home appliances company, is marking World Environment Day by highlighting a suite of technologies designed...
SARASOTA, Fla., June 5, 2026 /PRNewswire/ -- Pines of Sarasota Healthcare, LLC experienced a data security incident that involved personal and / or protected...
DALLAS, June 05, 2026 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc. (Nasdaq: TSHA) (Taysha or the Company), a clinical-stage biotechnology company focused on advancing adeno-associated virus (AAV)-based gene therapies for severe monogenic diseases of the central nervous system (CNS), today announced that, on June 1, 2026, the Compensation Committee of Taysha's Board of Directors granted four new employees, in the aggregate, restricted stock units (RSUs) representing 714,700 shares of the Company’s common stock and an option to purchase 468,600 shares of the Company's common stock in connection with their employment. The RSUs and stock option were granted under the Taysha Gene Therapies, Inc. 2023 Inducement Plan as an inducement material to the individuals entering employment with Taysha in accordance with Nasdaq Listing Rule 5635(c)(4).
TYSONS CORNER, Va. and PETAH TIKVA, Israel, June 5, 2026 /CNW/ -- Cellebrite DI Ltd. (NASDAQ: CLBT), a global leader in AI-powered Digital Investigative and Intelligence...